Search details
1.
Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF.
Circulation
; 2024 Jun 06.
Article
in English
| MEDLINE | ID: mdl-38841854
2.
Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation
; 149(23): 1789-1801, 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38583093
3.
Identification of three mechanistic pathways for iron-deficient heart failure.
Eur Heart J
; 2024 May 11.
Article
in English
| MEDLINE | ID: mdl-38733250
4.
Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes.
Circulation
; 148(4): 354-372, 2023 07 25.
Article
in English
| MEDLINE | ID: mdl-37486998
5.
Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure.
Circulation
; 148(13): 1011-1022, 2023 09 26.
Article
in English
| MEDLINE | ID: mdl-37621153
6.
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?
Circulation
; 148(9): 732-749, 2023 08 29.
Article
in English
| MEDLINE | ID: mdl-37366061
7.
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
N Engl J Med
; 385(16): 1451-1461, 2021 10 14.
Article
in English
| MEDLINE | ID: mdl-34449189
8.
Mechanistic and Clinical Comparison of the Erythropoietic Effects of SGLT2 Inhibitors and Prolyl Hydroxylase Inhibitors in Patients with Chronic Kidney Disease and Renal Anemia.
Am J Nephrol
; 55(2): 255-259, 2024.
Article
in English
| MEDLINE | ID: mdl-37231827
9.
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis.
Diabetes Obes Metab
; 26(7): 2578-2587, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38558314
10.
Fetal Reprogramming of Nutrient Surplus Signaling, O-GlcNAcylation, and the Evolution of CKD.
J Am Soc Nephrol
; 34(9): 1480-1491, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-37340541
11.
Mechanisms of enhanced renal and hepatic erythropoietin synthesis by sodium-glucose cotransporter 2 inhibitors.
Eur Heart J
; 44(48): 5027-5035, 2023 Dec 21.
Article
in English
| MEDLINE | ID: mdl-37086098
12.
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
Eur Heart J
; 44(5): 396-407, 2023 02 01.
Article
in English
| MEDLINE | ID: mdl-36478225
13.
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.
Eur Heart J
; 44(13): 1136-1153, 2023 04 01.
Article
in English
| MEDLINE | ID: mdl-36944496
14.
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
Eur Heart J
; 44(8): 668-677, 2023 02 21.
Article
in English
| MEDLINE | ID: mdl-36632831
15.
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial.
Eur Heart J
; 44(24): 2202-2212, 2023 06 25.
Article
in English
| MEDLINE | ID: mdl-37051752
16.
Stroke in patients with heart failure and reduced or preserved ejection fraction.
Eur Heart J
; 44(31): 2998-3013, 2023 08 14.
Article
in English
| MEDLINE | ID: mdl-37358785
17.
Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis.
Circulation
; 146(18): 1383-1405, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36315602
18.
Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes.
Circulation
; 146(9): 676-686, 2022 08 30.
Article
in English
| MEDLINE | ID: mdl-35762322
19.
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
Circulation
; 145(3): 184-193, 2022 01 18.
Article
in English
| MEDLINE | ID: mdl-34779658
20.
Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.
Circulation
; 146(14): 1046-1055, 2022 10 04.
Article
in English
| MEDLINE | ID: mdl-36098051